Recent Material Events - Replidyne, Inc (RDYN)

Filing Date	Description
2008-09-03	On May 13, 2008, Replidyne, Inc. (the “Company”) was served with a Demand for Arbitration (the “Demand”) from MEDA Manufacturing GmbH (f/k/a Tropon GmbH) (“MEDA”) alleging that the Company breached certain of its obligat ...
2008-08-27	On August 22, 2008, Replidyne, Inc. (the “Company”) commenced a restructuring of its operations pursuant to which it will incur approximately $3.1 million of expense representing $1.6 million in cash expenditures for employee related severa ...
2008-06-06	On June 5, 2008, Replidyne, Inc. (the “Company”) commenced and completed a restructuring of its operations pursuant to which it will incur approximately $0.7 million of expense representing cash expenditures for employee related severance b ...
2008-05-16	On May 13, 2008, Replidyne, Inc. (the “Company”) was served with a Demand for Arbitration (the “Demand”) from MEDA Manufacturing GmbH (f/k/a Tropon GmbH) (“MEDA”) alleging that the Company breached certain of its obligat ...
2008-05-07	On May 7, 2008, Replidyne, Inc. issued a press release reporting its results of operations for the first quarter 2008. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and incorporated by reference herein. ...
2008-05-06	(b) On May 1, 2008, in connection with a restructuring of its operations, Replidyne, Inc. (the “Company”) terminated the employment of Roger Echols, M.D., the Company’s Chief Medical Officer. The termination of Dr. Echols is the result ...
2008-04-16	(b) On April 15, 2008, in connection with a restructuring of its operations, Replidyne, Inc. (the “Company”) terminated the employment of Peter Letendre, Pharm.D., the Company’s Chief Commercial Officer. The termination of Dr. Letendre ...
2008-04-01	(e) On March 31, 2008, Replidyne, Inc. (the “Company”) entered into retention bonus agreements with each of Donald Morrissey and Mark Smith (the “Retention Bonus Agreements”). ...
2008-03-27	(b) On March 27, 2008, Christopher D. Earl, Ph.D. notified Replidyne, Inc. (the “Company”) of his resignation from the Board of Directors of the Company, effective immediately. ...
2007-12-10	On December 10, 2007, Replidyne issued a press release regarding an operational restructuring to align resources with strategic priorities. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K. ...